Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Membrane Oxygenators Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Membrane Oxygenators Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats From New Entrants
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Membrane Oxygenators Market: By Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Membrane Oxygenators Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Flat Sheet Membrane Oxygenator
4.3.1. Flat Sheet Membrane Oxygenators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Hollow Fibre Membrane Oxygenator
4.4.1. Hollow Fibre Membrane Oxygenators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Membrane Oxygenators Market: By Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Membrane Oxygenators Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Respiratory
5.3.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.1. Respiratory Failures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Pulmonary Embolism
5.3.2.1. Pulmonary Embolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Acute Respiratory Distress Syndrome
5.3.3.1. Acute Respiratory Distress Syndrome Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Pneumonia
5.3.4.1. Pneumonia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. COVID-19
5.3.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Cardiac
5.4.1. Cardiac Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Acute Myocardial Infarction
5.4.2.1. Acute Myocardial Infarction Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Myocarditis
5.4.3.1. Myocarditis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Post-Transplant Complications
5.4.4.1. Post-Transplant Complications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Cardiogenic Shock
5.4.5.1. Cardiogenic Shock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Extra Corporeal Cardiopulmonary Resuscitation
5.5.1. Extra Corporeal Cardiopulmonary Resuscitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Membrane Oxygenators Market: By Age group Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Membrane Oxygenators Market: Age Group Movement Analysis, 2023 & 2030 (USD Million)
6.2.1. Neonates
6.2.1.1. Neonates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. Pediatrics
6.2.2.1. Pediatrics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Adults
6.2.3.1. Adults Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Membrane Oxygenators Market: Regional Estimates & Trend Analysis
7.1. Membrane Oxygenators Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Demark
7.3.6.1. Denmark Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Sweden
7.3.7.1. Sweden Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Membrane Oxygenators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1 Medtronic
8.4.1.1 Participant’s Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Recent Developments/ Strategic Initiatives
8.4.2 Fresenius SE & Co KGaA;
8.4.2.1 Participant’s Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Recent Developments/ Strategic Initiatives
8.4.3 Getinge AB
8.4.3.1 Participant’s Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Recent Developments/ Strategic Initiatives
8.4.4 Terumo Medical Corporation
8.4.4.1 Participant’s Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Recent Developments/ Strategic Initiatives
8.4.5 MicroPort Scientific Corporation
8.4.5.1 Participant’s Overview
8.4.5.2 Financial Performance
8.4.5.3 Product Benchmarking
8.4.5.4 Recent Developments/ Strategic Initiatives
8.4.6 Nipro Medical Corporation
8.4.6.1 Participant’s Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Recent Developments/ Strategic Initiatives
8.4.7 Kewei Medical
8.4.7.1 Participant’s Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Recent Developments/ Strategic Initiatives
8.4.8 Braile Biomedica
8.4.8.1 Participant’s Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Recent Developments/ Strategic Initiatives
8.4.9 Livanova Plc
8.4.9.1 Participant’s Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Recent Developments/ Strategic Initiatives
8.4.10 Chalice Medical Ltd
8.4.10.1 Participant’s Overview
8.4.10.2 Financial Performance
8.4.10.3 Product Benchmarking
8.4.10.4 Recent Developments/ Strategic Initiatives